NXEN

NEXIEN BIOPHARMA INC by Nexien BioPharma, Inc. (NXEN)

About NEXIEN BIOPHARMA INC by Nexien BioPharma, Inc. (NXEN)

Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. Its flagship research and development programs are focused on advancing formulations to significantly improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders. The company was founded by Richard Greenberg on November 10, 1952 and is headquartered in Glendale, CO.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.05
52 Week Low
$0.00
Market cap
636,900
Dividend yield
0.00%
Volume
--
Avg. volume
3,087
P/E ratio
-2.81

NEXIEN BIOPHARMA INC by Nexien BioPharma, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.05
52 Week Low
$0.00
Market cap
636,900
Dividend yield
0.00%
Volume
--
Avg. volume
3,087
P/E ratio
-2.81